PEGylated Proteins Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET OVERVIEW

PEGylation is the process of covalent and non-covalent attachment of polyethylene glycol polymer chains to molecules, such as a drug, therapeutic protein, or vesicle. PEGylation increases stability and solubility of drug and reduces immunogenicity by altering the electrostatic binding, confirmation, and hydrophobicity of the molecule. A variety of proteins, therapeutic peptides, and small drug molecules have been PEGylated for the improvement or alteration of pharmacokinetic parameters in order to benefit from various consequences.

MARKET SCOPE

The "Global PEGylated Proteins Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the PEGylated Proteins market with detailed market segmentation by product, protein type, application, end user and geography. The report provides key statistics on the market status of the leading PEGylated Proteins market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

•   Based on product type, the global PEGylated Proteins market is segmented into Consumables, Services.
  
•   Based on protein type, the global PEGylated Proteins market is segmented into Colony Stimulating Factors, Interferons, Erythropoietin (EPO), Recombinant Factor Viii, Monoclonal Antibodies, Other Proteins.
  
•   Based on application, the global PEGylated Proteins market is segmented into Cancer Treatment, Hepatitis, Chronic Kidney Disease, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorder, Other Applications.
  
•   Based on distribution channel the global PEGylated Proteins market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organization, Academic Research Institutes.
  

MARKET DYNAMICS
Drivers:

•   Increase in R&D expenditure
  
•   Increase in adoption of protein-based drugs
  

Restraints:

•   PEGylation and Drug Failure & Recalls
  

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The PEGylated Proteins market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the PEGylated Proteins market in these regions.

IMPACT OF COVID-19 ON PEGYLATED PROTEINS MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. However, the demand for PEGylated Proteins has increased due to rising in COVID instances.

PEGylated Proteins Market Report Analysis

PEGylated Proteins Market

• 
  CAGR (2023 - 2031)

  XX%
• Market Size 2023
  US$ XX Million
• Market Size 2031
  US$ XX Million

Report Coverage

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis

• Industry landscape and competition analysis & recent developments
• Detailed company profiles

• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

• Merck KGaA
• Thermo Fisher Scientific Inc.
• NOF America Corporation
• JenKem Technology USA
• Creative PEGWorks
• celares GmbH
• QUANTA BIODESIGN, LTD.
• Biomatrik Inc.
• IRIS BIOTECH GMBH

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

By Product

• Consumables
• Services

By Protein Type

• Colony Stimulating Factors
• Interferons
• Erythropoietin
• Recombinant Factor Viii
• Monoclonal Antibodies
• Other Proteins

By Application

• Cancer Treatment
• Hepatitis
• Chronic Kidney Disease
• Hemophilia
• Multiple Sclerosis
• Gastrointestinal Disorder
• Other Applications

By End User

• Pharmaceutical & Biotechnology Companies
• Contract Research Organization
• Academic Research Institutes

MARKET PLAYERS

The report covers key developments in the PEGylated Proteins market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from PEGylated Proteins market are anticipated to lucrative growth opportunities in the future with the rising demand for PEGylated Proteins in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the PEGylated Proteins market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

•   Merck KGaA
  
•   Thermo Fisher Scientific Inc.
  
•   NOF America Corporation
  
•   JenKem Technology USA
  
•   Creative PEGWorks
  
•   celares GmbH
  
•   QUANTA BIODESIGN, LTD.
  
•   Biomatrik Inc.
  
•   IRIS BIOTECH GMBH
  
•   Laysan Bio, Inc.
  11. Creative PEGworks
  

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

PEGylated Proteins Market Report Scope